On the contrary, other evidence has shown that SFRP1 mutations found in glioblastoma and CRC promote cancer by compromising the senescence-inducing activity of SFRP1, thus failing to antagonize Wnt signaling [58]. This evidence concerns the gene SFRP1 and cancer.